Detection and Quantification of Nucleic Acids based on Argonaute Protein

This technology enables detection and quantification of multiple nucleic acid targets in a single sample for applications in biomedical research, diagnostics, and environmental monitoring. It partitions the sample into small reaction compartments, combining nucleic acid amplification with guide-directed Argonaute (Ago) enzymes that cleave reporters to generate detectable signals, while pyrophosphatase maintains magnesium availability to support the reaction. The approach is designed to combine quantitative detection with multiplexing, addressing limitations of isothermal amplification methods that are often nonquantitative and CRISPR-based assays whose collateral cleavage complicates detection of multiple targets. 

Researchers

Hanry Yu / Joshua Raymond / Xiaolin Wu / Stacy Springs

Departments: Center for Biomedical Innovation
Technology Areas: Diagnostics: Assays
Impact Areas: Healthy Living

  • methods of detecting target nucleic acids
    United States of America | Pending

Technology 

MOTOPIA stands for Multiplex Omni-purpose Technology in One-Pot via Isothermal amplification and Argonaute-based detection.  This technology platform combines rapid and precise absolute quantification of DNA through digital sample partitioning.  MOTOPIA can be used for detecting the presence in samples of one or more microbial contaminants, rare mutations, copy number variants, and/or SNP detections in a single reaction environment. First, isothermal amplification produces many copies of target DNA or RNA without requiring thermal cycling. Then, a designed single-stranded guide directs the Ago enzyme to cleave the amplified target DNA, producing a 5′-phosphorylated fragment that serves as a new guide for Ago to cleave a matching reporter and generate a fluorescent signal. Reporters with different fluorescent labels distinguish multiple targets, while pyrophosphatase maintains the magnesium availability needed for Ago activity. For quantification, the reaction can be divided into many small compartments, and detection across the compartments can be used to quantify target molecules. 

Problem Addressed 

Current nucleic acid detection methods face tradeoffs in speed, specificity, quantification, and the ability to detect multiple targets simultaneously. RT-qPCR requires precise thermal cycling and efficient amplification, while digital PCR takes longer, and rapid isothermal methods can produce nonspecific amplification and are often nonquantitative. CRISPR-based assays provide sensitive detection, but collateral cleavage by Cas enzymes complicates multiplexing. The present technology addresses these challenges by combining compartmentalized amplification with guide-directed Ago detection in one rection for target identification and quantification, with pyrophosphatase maintaining magnesium availability.  

Advantages 

  • Detection methods are rapid with sample turn-around time of less than a day 

  • Enables detection and quantification of a broad range of target nucleic acids through compartmentalized reactions with results comparable to that of qPCR 

  • Uses guide-directed Ago enzymes for sequence-specific detection and requires low sample input levels of nucleic acids 

  • Combines nucleic acid amplification and detection within the same reaction pot 

  • Maintains magnesium availability through pyrophosphatase activity to support the combined reaction 

  • Methods are sensitive enough to detect nucleic acid targets in cell lysates, removing the need to first prepare nucleic acid extracts from samples 

  • Rapid quantification of vector copy number in lysates from complex patient CAR-T cell cultures to assess clinical potency and safety of products during expansions and monitoring in vivo following patient infusions 

Publications 

Chan, Cheryl, Joanne Xin Yi Loh, Wei-Xiang Sin, et al. “Extracellular Viral MicroRNAs as Biomarkers of Virus Infection in Human Cells.” Molecular Therapy – Nucleic Acids 36, no. 1 (2025): 102444. https://doi.org/10.1016/j.omtn.2024.102444.  

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.